We are live on ! Find out more
JSMC

Jess S. Morgan & Co Portfolio holdings

AUM $115M
1-Year Est. Return 16.65%
This Fund
S&P 500
This Quarter Est. Return
+15.05%
1 Year Est. Return
-16.65%
3 Year Est. Return
+69.29%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$102M
AUM Growth
–
Cap. Flow
+$96M
Cap. Flow %
94.21%
Top 10 Hldgs %
37.52%
Holding
43
New
43
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$5.09M
2
IWV icon
iShares Russell 3000 ETF
IWV
+$4.61M
3
NVCR icon
NovoCure
NVCR
+$4.27M
4
AAPL icon
Apple
AAPL
+$3.46M
5
FEP icon
First Trust Europe AlphaDEX Fund
FEP
+$3.17M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 17.42%
2 Technology 14.07%
3 Financials 11.16%
4 Consumer Discretionary 5.42%
5 Industrials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBUX icon
26
Starbucks
SBUX
$120B
$2.61M 2.56%
+29,686
New +$2.53M
JNJ icon
27
Johnson & Johnson
JNJ
$618B
$2.58M 2.53%
+17,710
New +$2.4M
ADBE icon
28
Adobe
ADBE
$99.5B
$2.54M 2.49%
+7,711
New +$2.27M
DIS icon
29
Walt Disney
DIS
$167B
$2.42M 2.37%
+16,728
New +$2.33M
CRM icon
30
Salesforce
CRM
$151B
$2.3M 2.26%
+14,153
New +$2.22M
ARNA
31
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.95M 1.91%
+42,876
New +$2.03M
BMY icon
32
Bristol-Myers Squibb
BMY
$133B
$1.75M 1.71%
+27,236
New +$1.56M
XLK icon
33
State Street Technology Select Sector SPDR ETF
XLK
$115B
$1.6M 1.57%
+34,856
New +$1.49M
XLV icon
34
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
$814K 0.8%
+7,996
New +$769K
IGV icon
35
iShares Expanded Tech-Software Sector ETF
IGV
$12.7B
$754K 0.74%
+16,180
New +$717K
XLP icon
36
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
$631K 0.62%
+10,018
New +$617K
AXSM icon
37
Axsome Therapeutics
AXSM
$11.2B
$568K 0.56%
+5,500
New +$222K
ITCI
38
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$223K 0.22%
+6,500
New +$78K
ORMP icon
39
Oramed Pharmaceuticals
ORMP
$167M
$159K 0.16%
+30,900
New +$116K
RNTX
40
Rein Therapeutics
RNTX
$63.1M
$72K 0.07%
+6,250
New +$61.7K
BMY.RT
41
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$68K 0.07%
+22,446
New +$58.4K
AGEN
42
Agenus
AGEN
$312M
$41K 0.04%
+509
New +$34.2K
USWS
43
DELISTED
U.S. Well Services, Inc. Class A Common Stock
USWS
$19K 0.02%
+476
New +$17.3K
1
2

Similar funds

RCM
Rutabaga Capital Management Boston, Massachusetts $115M AUM 11.85% 1-Year Est. Return
DIV
DCM International VI Menlo Park, California $114M AUM 73.96% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return
FFC
Fure Financial Corporation Bloomington, Minnesota $122M AUM 1.51% 1-Year Est. Return
SA
SWM Advisors St. Petersburg, Florida $106M AUM 17.51% 1-Year Est. Return
MCA
Morris Capital Advisors Malvern, Pennsylvania $106M AUM 2.55% 1-Year Est. Return
SCM
Salem Capital Management Woburn, Massachusetts $126M AUM 8.82% 1-Year Est. Return
LAM
LFS Asset Management San Ramon, California $99.1M AUM

Jess S. Morgan & Co's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Jess S. Morgan & Co, which disclosed 43 positions worth $102M. Its ten largest holdings account for 38% of the portfolio.

Its largest position is Invesco QQQ Trust: 25,435 shares worth $5.41M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, followed by Technology and Financials.

  • Jess S. Morgan & Co's largest Q4 2019 buy was Invesco QQQ Trust: 25,435 shares worth $5.41M.
  • Jess S. Morgan & Co's ten largest holdings make up 38% of its $102M portfolio in Q4 2019.
  • Jess S. Morgan & Co disclosed 43 positions in Q4 2019, its first 13F filing on record.

Based on Jess S. Morgan & Co's 13F filing for Q4 2019, filed 19 Nov 2021.